[go: up one dir, main page]

ES2104509A1 - New compounds derived from 2-[3,4-disubstituted-1- piperazinyl]-5-fluoropyrimidine - Google Patents

New compounds derived from 2-[3,4-disubstituted-1- piperazinyl]-5-fluoropyrimidine

Info

Publication number
ES2104509A1
ES2104509A1 ES09501182A ES9501182A ES2104509A1 ES 2104509 A1 ES2104509 A1 ES 2104509A1 ES 09501182 A ES09501182 A ES 09501182A ES 9501182 A ES9501182 A ES 9501182A ES 2104509 A1 ES2104509 A1 ES 2104509A1
Authority
ES
Spain
Prior art keywords
fluoropyrimidine
disubstituted
piperazinyl
new compounds
compounds derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09501182A
Other languages
Spanish (es)
Other versions
ES2104509B1 (en
Inventor
Ambros Rafael Foguet
Ribera Santiago Gubert
Hernandez Jose A Ortiz
Munoz Aurelio Sacristan
Barenys Josep Maria Castello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Priority to ES9501182A priority Critical patent/ES2104509B1/en
Publication of ES2104509A1 publication Critical patent/ES2104509A1/en
Application granted granted Critical
Publication of ES2104509B1 publication Critical patent/ES2104509B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

New compounds derived from 2-[3,4-disubstituted-1- piperazinyl]-5-fluoropyrimidine New compounds derived from 2-[3,4-disubstituted-1- piperazinyl]-5-fluoropyrimidine of general formula I: < IMAGE > where R indicates methyl and X indicates carbonyl or hydroxymethyl, and their stereoisomers and pharmaceutically acceptable addition salts useful in the treatment of psychosis, schizophrenia and anxiety.
ES9501182A 1995-06-13 1995-06-13 NEW COMPOUNDS DERIVED FROM 2- (3,4-DISSTITUTED-1-PIPERAZINYL) -5-FLUOROPYRIMIDINE. Expired - Fee Related ES2104509B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9501182A ES2104509B1 (en) 1995-06-13 1995-06-13 NEW COMPOUNDS DERIVED FROM 2- (3,4-DISSTITUTED-1-PIPERAZINYL) -5-FLUOROPYRIMIDINE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9501182A ES2104509B1 (en) 1995-06-13 1995-06-13 NEW COMPOUNDS DERIVED FROM 2- (3,4-DISSTITUTED-1-PIPERAZINYL) -5-FLUOROPYRIMIDINE.

Publications (2)

Publication Number Publication Date
ES2104509A1 true ES2104509A1 (en) 1997-10-01
ES2104509B1 ES2104509B1 (en) 1998-07-01

Family

ID=8290727

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9501182A Expired - Fee Related ES2104509B1 (en) 1995-06-13 1995-06-13 NEW COMPOUNDS DERIVED FROM 2- (3,4-DISSTITUTED-1-PIPERAZINYL) -5-FLUOROPYRIMIDINE.

Country Status (1)

Country Link
ES (1) ES2104509B1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592450B2 (en) * 2002-03-13 2009-09-22 Janssen Pharmaceutica N.V. Piperazinyl-, piperidinyl- and morpholinyl-derivatives as inhibitors of histone deacetylase
US8071615B2 (en) 2002-03-13 2011-12-06 Janssen Pharmaceutica N.V. Carbonylamino-derivatives as novel inhibitors of histone deacetylase
US8101616B2 (en) 2006-01-19 2012-01-24 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
US8114999B2 (en) 2002-03-13 2012-02-14 Janssen Pharmaceutica N.V. Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
US8114876B2 (en) 2006-01-19 2012-02-14 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
US8119650B2 (en) 2006-01-19 2012-02-21 Janssen Pharmaceutica N.V. Aminophenyl derivatives as novel inhibitors of histone deacetylase
US8138198B2 (en) 2005-05-18 2012-03-20 Angibaud Patrick Rene Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
US8163733B2 (en) 2002-03-13 2012-04-24 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
US8163765B2 (en) 2006-01-19 2012-04-24 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
US9636341B2 (en) 2004-07-28 2017-05-02 Janssen Pharmaceutica N.V. Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
FR2073326A1 (en) * 1969-11-04 1971-10-01 Sumitomo Chemical Co
ES8607254A1 (en) * 1984-03-06 1986-05-16 Bristol Myers Co Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
EP0400661A1 (en) * 1989-06-01 1990-12-05 Bristol-Myers Squibb Company Agents for treatment of brain ischemia

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
FR2073326A1 (en) * 1969-11-04 1971-10-01 Sumitomo Chemical Co
ES8607254A1 (en) * 1984-03-06 1986-05-16 Bristol Myers Co Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
EP0400661A1 (en) * 1989-06-01 1990-12-05 Bristol-Myers Squibb Company Agents for treatment of brain ischemia

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8268833B2 (en) 2002-03-13 2012-09-18 Janssen Pharmaceutica, N.V. Inhibitors of histone deacetylase
US8455498B2 (en) 2002-03-13 2013-06-04 Janssen Pharmaceutica N.V. Inhibitors of histone deacetylase
US8501737B2 (en) 2002-03-13 2013-08-06 Janssen Pharmaceutica N.V. Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
US8114999B2 (en) 2002-03-13 2012-02-14 Janssen Pharmaceutica N.V. Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
US7592450B2 (en) * 2002-03-13 2009-09-22 Janssen Pharmaceutica N.V. Piperazinyl-, piperidinyl- and morpholinyl-derivatives as inhibitors of histone deacetylase
US9556161B2 (en) 2002-03-13 2017-01-31 Janssen Pharmaceutica Nv Inhibitors of histone deacetylase
US8524711B2 (en) 2002-03-13 2013-09-03 Janssen Pharmaceutica N.V. Amino-derivatives as novel inhibitors of histone deacetylase
US8163733B2 (en) 2002-03-13 2012-04-24 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
US8071615B2 (en) 2002-03-13 2011-12-06 Janssen Pharmaceutica N.V. Carbonylamino-derivatives as novel inhibitors of histone deacetylase
US8513237B2 (en) 2002-03-13 2013-08-20 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
US8343988B2 (en) 2002-03-13 2013-01-01 Janssen Pharmaceutica, N.V Inhibitors of histone deacetylase
US8394831B2 (en) 2002-03-13 2013-03-12 Janssen Pharmaceutica, N.V. Carbonylamino-derivatives as novel inhibitors of histone deacetylase
US9636341B2 (en) 2004-07-28 2017-05-02 Janssen Pharmaceutica N.V. Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
US8138198B2 (en) 2005-05-18 2012-03-20 Angibaud Patrick Rene Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
US8114876B2 (en) 2006-01-19 2012-02-14 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
US8163765B2 (en) 2006-01-19 2012-04-24 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
US8664223B2 (en) 2006-01-19 2014-03-04 Janssen Pharmaceutica N.V Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
US8119650B2 (en) 2006-01-19 2012-02-21 Janssen Pharmaceutica N.V. Aminophenyl derivatives as novel inhibitors of histone deacetylase
US8101616B2 (en) 2006-01-19 2012-01-24 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase

Also Published As

Publication number Publication date
ES2104509B1 (en) 1998-07-01

Similar Documents

Publication Publication Date Title
IL114894A0 (en) Endothelin antagonists
PL315059A1 (en) 5-(2-imidazolynynamino) benzimidazole derivatives, method of obtaining them and their application as antagonists of a-2-andrenoceptors
ES2134847T3 (en) DERIVATIVES OF TAXOL.
ES2158537T3 (en) DERIVATIVES OF CYCLOPROPILALCANOIC ACIDS.
IL119207A0 (en) Treatment of tinnitus using neuroprotective agents
HU9302933D0 (en) Heterocyclic compounds
GB9502644D0 (en) Heterocyclic derivatives
ES2104509A1 (en) New compounds derived from 2-[3,4-disubstituted-1- piperazinyl]-5-fluoropyrimidine
HUT65876A (en) Process for producing antiretroviral tripeptide derivatives
TW252979B (en)
MX9804828A (en) Biologically active benzothiazolone ethanamines.
DK0664811T3 (en) Gestagent active 4-estrener with bridge between positions 19,11
ZA961044B (en) New pyridine and pyridazine derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
ES2101620A1 (en) New compound derived from chromene
ES2103237A1 (en) New compound derived from chromene
FR2729861B3 (en) CATHETER, ESPECIALLY FOR ENDOSCOPY OF THE BILIARY WAYS
DK293889A (en) 2-AMINO-7-HYDROXYTETRALINETHERE

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971001

Kind code of ref document: A1

Effective date: 19971001

FD1A Patent lapsed

Effective date: 20020401